153 related articles for article (PubMed ID: 22301880)
41. Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C).
Marquez VE; Blumberg PM
Acc Chem Res; 2003 Jun; 36(6):434-43. PubMed ID: 12809530
[TBL] [Abstract][Full Text] [Related]
42. Elucidating the interaction of γ-hydroxymethyl-γ-butyrolactone substituents with model membranes and protein kinase C-C1 domains.
Borah R; Mamidi N; Panda S; Gorai S; Pathak SK; Manna D
Mol Biosyst; 2015 May; 11(5):1389-99. PubMed ID: 25820877
[TBL] [Abstract][Full Text] [Related]
43. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
Sugimoto T; Itagaki K; Irie K
Bioorg Med Chem; 2008 Jan; 16(2):650-7. PubMed ID: 17977729
[TBL] [Abstract][Full Text] [Related]
44. Diacylglycerol-induced membrane targeting and activation of protein kinase Cepsilon: mechanistic differences between protein kinases Cdelta and Cepsilon.
Stahelin RV; Digman MA; Medkova M; Ananthanarayanan B; Melowic HR; Rafter JD; Cho W
J Biol Chem; 2005 May; 280(20):19784-93. PubMed ID: 15769752
[TBL] [Abstract][Full Text] [Related]
45. A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production.
Dries DR; Gallegos LL; Newton AC
J Biol Chem; 2007 Jan; 282(2):826-30. PubMed ID: 17071619
[TBL] [Abstract][Full Text] [Related]
46. Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta.
Czikora A; Pany S; You Y; Saini AS; Lewin NE; Mitchell GA; Abramovitz A; Kedei N; Blumberg PM; Das J
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1046-1056. PubMed ID: 29317197
[TBL] [Abstract][Full Text] [Related]
47. The guanine nucleotide exchange factor RasGRP is a high -affinity target for diacylglycerol and phorbol esters.
Lorenzo PS; Beheshti M; Pettit GR; Stone JC; Blumberg PM
Mol Pharmacol; 2000 May; 57(5):840-6. PubMed ID: 10779365
[TBL] [Abstract][Full Text] [Related]
48. Characterization of AJH-836, a diacylglycerol-lactone with selectivity for novel PKC isozymes.
Cooke M; Zhou X; Casado-Medrano V; Lopez-Haber C; Baker MJ; Garg R; Ann J; Lee J; Blumberg PM; Kazanietz MG
J Biol Chem; 2018 Jun; 293(22):8330-8341. PubMed ID: 29636415
[TBL] [Abstract][Full Text] [Related]
49. Defining the human targets of phorbol ester and diacylglycerol.
Geiger M; Wrulich OA; Jenny M; Schwaiger W; Grunicke HH; Uberall F
Curr Opin Mol Ther; 2003 Dec; 5(6):631-41. PubMed ID: 14755890
[TBL] [Abstract][Full Text] [Related]
50. Molecular basis for failure of "atypical" C1 domain of Vav1 to bind diacylglycerol/phorbol ester.
Geczy T; Peach ML; El Kazzouli S; Sigano DM; Kang JH; Valle CJ; Selezneva J; Woo W; Kedei N; Lewin NE; Garfield SH; Lim L; Mannan P; Marquez VE; Blumberg PM
J Biol Chem; 2012 Apr; 287(16):13137-58. PubMed ID: 22351766
[TBL] [Abstract][Full Text] [Related]
51. Phorbol esters modulate the Ras exchange factor RasGRP3.
Lorenzo PS; Kung JW; Bottorff DA; Garfield SH; Stone JC; Blumberg PM
Cancer Res; 2001 Feb; 61(3):943-9. PubMed ID: 11221888
[TBL] [Abstract][Full Text] [Related]
52. Fluorescence-quenching screening of protein kinase C ligands with an environmentally sensitive fluorophore.
Nomura W; Ohashi N; Okuda Y; Narumi T; Ikura T; Ito N; Tamamura H
Bioconjug Chem; 2011 May; 22(5):923-30. PubMed ID: 21434694
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the differential roles of the twin C1a and C1b domains of protein kinase C-delta.
Pu Y; Garfield SH; Kedei N; Blumberg PM
J Biol Chem; 2009 Jan; 284(2):1302-12. PubMed ID: 19001377
[TBL] [Abstract][Full Text] [Related]
54. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
Thangsunan P; Tateing S; Hannongbua S; Suree N
J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
[TBL] [Abstract][Full Text] [Related]
55. Kinetic analysis of the interaction of the C1 domain of protein kinase C with lipid membranes by stopped-flow spectroscopy.
Dries DR; Newton AC
J Biol Chem; 2008 Mar; 283(12):7885-93. PubMed ID: 18187412
[TBL] [Abstract][Full Text] [Related]
56. Novel "nonkinase" phorbol ester receptors: the C1 domain connection.
Kazanietz MG
Mol Pharmacol; 2002 Apr; 61(4):759-67. PubMed ID: 11901214
[TBL] [Abstract][Full Text] [Related]
57. Protein kinase C ligands based on tetrahydrofuran templates containing a new set of phorbol ester pharmacophores.
Lee J; Kang JH; Lee SY; Han KC; Torres CM; Bhattacharyya DK; Blumberg PM; Marquez VE
J Med Chem; 1999 Oct; 42(20):4129-39. PubMed ID: 10514283
[TBL] [Abstract][Full Text] [Related]
58. beta2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its C1 domain.
Caloca MJ; Garcia-Bermejo ML; Blumberg PM; Lewin NE; Kremmer E; Mischak H; Wang S; Nacro K; Bienfait B; Marquez VE; Kazanietz MG
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11854-9. PubMed ID: 10518540
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the ligand binding site of C1 domains: a molecular dynamics simulation study of the C1 domain-phorbol 13-acetate-membrane system.
You Y; Mathukumalli K; Das J
J Biomol Struct Dyn; 2023; 41(21):11796-11809. PubMed ID: 36602779
[TBL] [Abstract][Full Text] [Related]
60. Structural anatomy of Protein Kinase C C1 domain interactions with diacylglycerol and other agonists.
Katti SS; Krieger IV; Ann J; Lee J; Sacchettini JC; Igumenova TI
Nat Commun; 2022 May; 13(1):2695. PubMed ID: 35577811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
